Literature DB >> 366146

A critical review of the effect of levamisole in rheumatic diseases other than rheumatoid arthritis.

M Rosenthal.   

Abstract

Levamisole has been used in several rheumatic diseases other than rheumatoid arthritis (RA). These include systemic lupus erythematosus (SLE), polymyositis/dermatomyositis, scleroderma, Sjögren's syndrome, psoriatic arthritis, ankylosing spondylitis, Reiter's syndrome and juvenile rheumatoid arthritis. Most of the published data have either been case reports including very few patients or have been concerned with specific clinical or laboratory assessments. It was therefore very difficult to make any reliable evaluation of the effect of levamisole in these conditions. Levamisole might have had some beneficial effect in some of the diseases listed but properly conducted, controlled trials are necessary before any definitive assessment can be made.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 366146

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  3 in total

Review 1.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

2.  HLA-B27-mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis.

Authors:  Chin-Hsiu Liu; Sengupta Raj; Chun-Hsiung Chen; Kuo-Hsuan Hung; Chung-Tei Chou; Ing-Ho Chen; Jui-Teng Chien; I-Ying Lin; Shii-Yi Yang; Takashi Angata; Wen-Chan Tsai; James Cheng-Chung Wei; I-Shiang Tzeng; Shih-Chieh Hung; Kuo-I Lin
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

Review 3.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.